These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 11376126

  • 1. Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects.
    Dupont J, Le Roith D.
    Mol Pathol; 2001 Jun; 54(3):149-54. PubMed ID: 11376126
    [Abstract] [Full Text] [Related]

  • 2. The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components.
    Dupont J, Karas M, LeRoith D.
    J Biol Chem; 2000 Nov 17; 275(46):35893-901. PubMed ID: 10967123
    [Abstract] [Full Text] [Related]

  • 3. The cyclin-dependent kinase inhibitor p21CIP/WAF is a positive regulator of insulin-like growth factor I-induced cell proliferation in MCF-7 human breast cancer cells.
    Dupont J, Karas M, LeRoith D.
    J Biol Chem; 2003 Sep 26; 278(39):37256-64. PubMed ID: 12867429
    [Abstract] [Full Text] [Related]

  • 4. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
    Lee AW, Nambirajan S, Moffat JG.
    Oncogene; 1999 Dec 09; 18(52):7477-94. PubMed ID: 10602507
    [Abstract] [Full Text] [Related]

  • 5. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 6. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase.
    Dufourny B, Alblas J, van Teeffelen HA, van Schaik FM, van der Burg B, Steenbergh PH, Sussenbach JS.
    J Biol Chem; 1997 Dec 05; 272(49):31163-71. PubMed ID: 9388270
    [Abstract] [Full Text] [Related]

  • 7. Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1).
    Lai A, Sarcevic B, Prall OW, Sutherland RL.
    J Biol Chem; 2001 Jul 13; 276(28):25823-33. PubMed ID: 11337496
    [Abstract] [Full Text] [Related]

  • 8. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.
    Hamelers IH, van Schaik RF, van Teeffelen HA, Sussenbach JS, Steenbergh PH.
    Exp Cell Res; 2002 Feb 01; 273(1):107-17. PubMed ID: 11795951
    [Abstract] [Full Text] [Related]

  • 9. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.
    Varma H, Conrad SE.
    Cancer Res; 2002 Jul 15; 62(14):3985-91. PubMed ID: 12124331
    [Abstract] [Full Text] [Related]

  • 10. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV.
    Cancer Res; 2001 Aug 01; 61(15):5771-7. PubMed ID: 11479214
    [Abstract] [Full Text] [Related]

  • 11. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA, Surmacz E.
    Cancer Res; 1997 Jul 01; 57(13):2606-10. PubMed ID: 9205064
    [Abstract] [Full Text] [Related]

  • 12. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.
    Jackson JG, White MF, Yee D.
    J Biol Chem; 1998 Apr 17; 273(16):9994-10003. PubMed ID: 9545345
    [Abstract] [Full Text] [Related]

  • 13. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
    Beery R, Haimsohn M, Wertheim N, Hemi R, Nir U, Karasik A, Kanety H, Geier A.
    Endocrinology; 2001 Jul 17; 142(7):3098-107. PubMed ID: 11416032
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells.
    Hamelers IH, van Schaik RF, Sipkema J, Sussenbach JS, Steenbergh PH.
    J Biol Chem; 2002 Dec 06; 277(49):47645-52. PubMed ID: 12364325
    [Abstract] [Full Text] [Related]

  • 15. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes.
    Wang W, Smith R, Safe S.
    Arch Biochem Biophys; 1998 Aug 15; 356(2):239-48. PubMed ID: 9705214
    [Abstract] [Full Text] [Related]

  • 16. Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
    Abroun S, Ishikawa H, Tsuyama N, Liu S, Li FJ, Otsuyama K, Zheng X, Obata M, Kawano MM.
    Blood; 2004 Mar 15; 103(6):2291-8. PubMed ID: 14592826
    [Abstract] [Full Text] [Related]

  • 17. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH, Byron SA, Cui X, Lee AV, Yee D.
    Mol Cancer Res; 2008 Sep 15; 6(9):1491-8. PubMed ID: 18819936
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
    Richards RG, Walker MP, Sebastian J, DiAugustine RP.
    J Biol Chem; 1998 May 08; 273(19):11962-9. PubMed ID: 9565625
    [Abstract] [Full Text] [Related]

  • 19. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.
    Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306
    [Abstract] [Full Text] [Related]

  • 20. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.
    Hermanto U, Zong CS, Li W, Wang LH.
    Mol Cell Biol; 2002 Apr 01; 22(7):2345-65. PubMed ID: 11884618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.